蒙泰高新 reported revenue of ¥0.26B for the period ended 2026-06-30, +5.4% year on year. Net income was ¥-0.02B, a -6.9% net margin on a 5.9% gross margin. The largest revenue line is 常规丙纶长丝 at 48% of the total. Free cash flow for the period was ¥-0.07B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.26B | +5.4% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 5.9% | Net margin -6.9% |
| Revenue Q/Q | +14.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 常规丙纶长丝 | ¥0.12B | 48.3% |
| 差别化丙纶长丝 | ¥0.12B | 47.2% |
| 锦纶丝 | ¥0.01B | 3.5% |
| 其他(补充) | ¥0.00B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.24B | 94.1% |
| R&D | ¥0.01B | 3.9% |
| SG&A | ¥0.02B | 8.2% |
| Tax & other | ¥0.00B | 0.1% |
| Item | Amount |
|---|---|
| Total assets | ¥1.89B |
| Total liabilities | ¥0.77B |
| Shareholders' equity | ¥1.12B |
| Equity / assets | 59.5% |
| Operating cash flow | ¥-0.02B |
| Capital expenditure | ¥0.05B |
| Free cash flow | ¥-0.07B |
| Cash conversion (OCF / net income) | -44% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
金春股份 ・ 维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得 ・ 狄耐克 ・ 海昌新材 ・ 华业香料 ・ 谱尼测试 ・ 稳健医疗
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies